DECIPHERA PHARMACEUTICALS IN - COM (DCPH)

Historical Portfolio Holders from Q3 2017 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
50K
Holdings value Q2 2024
$759K
Value change Q2 2024
-$935M
Grand Portfolio weight change Q2 2024
-0.002%
Number of holders
1
Number of buys Q2 2024
0
Number of sells Q2 2024
-170
Average buys Q2 2024 %
0
Average sells Q2 2024 %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 50K $759K -$935M $15.18 1
2024 Q1 59.6M $937M +$25.3M $15.73 175
2023 Q4 58M $935M +$34.9M $16.13 162
2023 Q3 56.2M $715M -$2.53M $12.72 154
2023 Q2 56.2M $792M -$26M $14.08 143
2023 Q1 58M $897M +$84.8M $15.45 146
2022 Q4 52.3M $856M +$350K $16.39 142
2022 Q3 49.1M $908M +$8.38M $18.50 150
2022 Q2 47.9M $630M +$67.8M $13.15 120
2022 Q1 43.5M $403M -$23.3M $9.27 114
2021 Q4 45.8M $447M -$377M $9.77 134
2021 Q3 42.7M $1.45B -$28.2M $33.98 160
2021 Q2 42.1M $1.54B -$3.93M $36.61 141
2021 Q1 43M $1.93B -$28.6M $44.84 163
2020 Q4 43.2M $2.46B +$28M $57.07 181
2020 Q3 42.5M $2.18B -$15.4M $51.30 162
2020 Q2 42.6M $2.51B +$114M $59.72 166
2020 Q1 40.7M $1.68B +$188M $41.17 146
2019 Q4 35.7M $2.22B +$26.4M $62.24 152
2019 Q3 35.4M $1.2B +$426M $33.94 121
2019 Q2 23.1M $522M +$15.3M $22.55 86
2019 Q1 22.5M $522M +$15M $23.21 80
2018 Q4 21.9M $460M -$21M $20.99 78
2018 Q3 21.2M $820M +$17.3M $38.72 88
2018 Q2 20.8M $819M +$205M $39.35 89
2018 Q1 15.6M $313M -$5.21M $20.04 54
2017 Q4 15.7M $355M +$31.5M $22.67 59
2017 Q3 14.6M $272M +$272M $18.99 50